title: Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.
abstract: OBJECTIVE
  To evaluate the clinical and biochemical profile of patients with non alcoholic fatty liver disease (NAFLD) and to assess their histological severity at presentation.
  
  
  METHODS
  Consecutive patients presenting to the liver clinic of All India Institute of Medical Sciences (AIIMS) with raised transaminases to at least 1.5 times upper limit of normal, and histologically confirmed non-alcoholic fatty liver disease were included. Patients who had significant alcohol intake or positive markers of other liver diseases or who were taking drugs known to produce fatty liver were excluded. The clinical, biochemical and histological profile of this group was studied.
  
  
  RESULTS
  Fifty-one patients with NAFLD formed the study population. Their median age and BMI were 34(17-58) years and 26.7(21.3-32.5) kg/m(2) respectively and 46 (90.1%) were males. The majority of the patients had mild inflammation, either grade 1 [32 (63%)] or grade 2 [16 (31%)] and only 3 (6%) patients had severe (grade 3) inflammation. Twenty-three (45%), 19 (37%), 8(16%) and 1(2%) patient had stage 0, 1, 2 and 3 fibrosis respectively on index biopsy and none had cirrhosis. On univariate analysis, triglyceride levels more than 150 mg % (OR = 7.1; 95% CI: 1.6-31.5, P = 0.002) and AST/ALT ratio>1 (OR = 14.3; 95% CI: 1.4-678.5, P = 0.008) were associated with high grades of inflammation and none was associated with advanced fibrosis. On multivariate logistic regression analysis, hypertriglyceridemia >150 mg% was the only factor independently associated with presence of high grade of inflammation (OR = 1.6; 95% CI: 1.3-22.7, P = 0.02), while none was associated with advanced fibrosis. Triglyceride levels correlated positively with inflammatory grade (r = 0.412; P = 0.003).
  
  
  CONCLUSIONS
  NAFLD in North Indian patients is a disease of young over-weight males, most of whom are insulin resistant and they tend to have a mild histological disease at presentation.
authors.affiliation: Department of Gastroenterology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
authors.forename: Kaushal
authors.initials: K
authors.lastname: Madan
authors.forename: Yogesh
authors.initials: Y
authors.lastname: Batra
authors.forename: S Datta
authors.initials: SD
authors.lastname: Gupta
authors.forename: Bal
authors.initials: B
authors.lastname: Chander
authors.forename: K D Anand
authors.initials: KD
authors.lastname: Rajan
authors.forename: M S
authors.initials: MS
authors.lastname: Tewatia
authors.forename: S K
authors.initials: SK
authors.lastname: Panda
authors.forename: S K
authors.initials: SK
authors.lastname: Acharya
mesh_terms: D000293:Adolescent; D000328:Adult; D044466:Asian People / Q000208:ethnology; D003430:Cross-Sectional Studies; D005234:Fatty Liver / Q000208:ethnology* / Q000473:pathology*; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000150:complications; D015994:Incidence; D007194:India / Q000208:ethnology; D007249:Inflammation; D007333:Insulin Resistance; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000208:ethnology / Q000473:pathology; D008875:Middle Aged; D050177:Overweight; D011446:Prospective Studies; D012720:Severity of Illness Index; D000637:Transaminases / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D014280:Triglycerides; D000637:Transaminases